Dr. Anette DuensingUniversity of Pittsburg Cancer Center | Dr. Anette Duensing studied medicine in Germany and the U.K., and received her M.D. from the University of Hannover Medical School, Germany. She wrote her dissertation on molecular genetics of liver tumors in the Department of Pathology at the University of Hannover Medical School. Dr. Duensing then completed three years of residency training in this department, where she participated mainly in the morphological and molecular diagnosis of hematological diseases. In 1999, Dr. Duensing joined Dr. Jonathan Fletcher's laboratory at the Brigham and Women's Hospital in Boston for a post‐doctoral fellowship. In the past few years, she has been leading the GIST‐related studies in Dr. Fletcher's lab. During that time, most of her research was focused on activated intracellular signaling pathways in GISTs that are triggered by the mutant KIT protein. This research has led to the identification of proteins which might be targeted by new kinase inhibitors as a complement to KIT inhibition. Since 2003, Dr. Duensing is Research Assistant Professor in the Department of Pathology at the University of Pittsburgh Medical School. |
|---|
